Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pioglitazone treatment in Cushing's disease.

× No keyword cloud information.

5 in total

1. Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.

Authors: S Aronoff; S Rosenblatt; S Braithwaite; J W Egan; A L Mathisen; R L Schneider
Journal: Diabetes Care Date: 2000-11 Impact factor: 19.112

2. Functional PPAR-gamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas.

Authors: Anthony P Heaney; Manory Fernando; William H Yong; Shlomo Melmed
Journal: Nat Med Date: 2002-10-15 Impact factor: 53.440

3. Baseline and CRH-stimulated ACTH and cortisol levels after administration of the peroxisome proliferator-activated receptor-gamma ligand, rosiglitazone, in Cushing's disease.

Authors: S Cannavò; B Ambrosi; I Chiodini; T Vigo; A Russo; C Milici; L Barbetta; C Dall'Asta; G Adda; M Arosio
Journal: J Endocrinol Invest Date: 2004-05 Impact factor: 4.256

Review 4. Peroxisome proliferator activated receptor-gamma ligands as potent antineoplastic agents.

Authors: S Theocharisa; A Margeli; G Kouraklis
Journal: Curr Med Chem Anticancer Agents Date: 2003-05

5. Effects of chronic administration of PPAR-gamma ligand rosiglitazone in Cushing's disease.

Authors: Bruno Ambrosi; Chiara Dall'Asta; Salvatore Cannavo; Rossella Libe; Teresa Vigo; Paolo Epaminonda; Iacopo Chiodini; Stefano Ferrero; Francesco Trimarchi; Maura Arosio; Paolo Beck-Peccoz
Journal: Eur J Endocrinol Date: 2004-08 Impact factor: 6.664

5 in total

1 in total

Review 1. The Treatment of Cushing's Disease.

Authors: Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal: Endocr Rev Date: 2015-06-11 Impact factor: 19.871

1 in total